Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1974
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: No guideline study, non-GLP study but conducted according to valid scientific standards still acceptable compared to nowadays existing guidelines. Study sufficiently reported and documented.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974
Report date:
1974

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
10 i.c. injections within 14 days of first induction phase; 2 challenge treatments
GLP compliance:
no
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The in vivo study data were obtained in studies performed before any in vitro sensitization tests had been validated and accepted for regulatory purposes

Test material

Constituent 1
Chemical structure
Reference substance name:
Sulfonic acids, C14-17-sec-alkane, sodium salts
EC Number:
307-055-2
EC Name:
Sulfonic acids, C14-17-sec-alkane, sodium salts
Cas Number:
97489-15-1
Molecular formula:
H3C-(CH2)m-CH-(SO3Na)-(CH2)n-CH3
IUPAC Name:
Sulfonic acids, C14-17-sec-alkane, sodium salts
Constituent 2
Reference substance name:
307-055-1
IUPAC Name:
307-055-1
Constituent 3
Reference substance name:
Hostapur SAS 60
IUPAC Name:
Hostapur SAS 60
Details on test material:
- Name of test material (as cited in study report): Hostapur SAS 60
- Physical state: pasty
- Analytical purity: 60%
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: 60% Hostapur SAS 93, water
- Isomers composition: n.a.
- Purity test date: 60%
- Lot/batch No.: no data
- Expiration date of the lot/batch: 1976
- Radiochemical purity (if radiolabelling): n.a.
- Specific activity (if radiolabelling): n.a.
- Locations of the label (if radiolabelling): n.a.
- Expiration date of radiochemical substance (if radiolabelling): n.a.
- Stability under test conditions: stability and homogeneity guaranteed
- Storage condition of test material: no data
- Other:

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Pirbright white
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: in house breeding
- Age at study initiation: young adult
- Weight at study initiation: no data
- Housing: stainless steel cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 +/- 3 °C
- Humidity (%): 50 +/- 20 %
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12 hours

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal
Vehicle:
water
Challenge
Route:
epicutaneous, occlusive
Vehicle:
water
No. of animals per dose:
6 animals for irritation screen
15 animals for main study
Details on study design:
RANGE FINDING TESTS: Yes, irritation screen with 6 animals


MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 10 intradermal injections
- Exposure period: 24 hours
- Test groups: 1
- Control group: 1
- Concentrations: 0.0 mL of a solution of 500 mg Hostapur SAS in 10 mL Freund`s complete adjuvans for intradermal induction



B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: 1
- Exposure period: 24 hours
- Test groups: 1
- Control group: 1
- Concentrations: 5% in water
- Evaluation (hr after challenge): 24 and 48 hours after each challenge treatment

Challenge controls:
Yes
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
5%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
5%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
none
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
5%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
none
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
Reading:
rechallenge
Hours after challenge:
24
Group:
test chemical
Dose level:
5%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Reading:
rechallenge
Hours after challenge:
24
Group:
negative control
Dose level:
5%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
none
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
Reading:
rechallenge
Hours after challenge:
48
Group:
test chemical
Dose level:
5%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Reading:
rechallenge
Hours after challenge:
48
Group:
negative control
Dose level:
5%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
none
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
Classification: not sensitizing
Executive summary:

Sec-alkane sulfonate-sodium salts SAS (60%) was examined for its capacity to cause contact allergy by the maximization test according to Magnusson and Kligman with guinea pigs. Based on a screening study using groups of 6 male guinea pigs the highest non-irritating concentration of sec-alkane sulfonate-sodium salts SAS (60%) was established to be 5% in water. In the main study 15 male guinea pigs were used. Induction exposure included 10 intracutaneous injections of 0.05 mL of a solution of 500 mg sec-alkane sulfonate-sodium salts SAS (60%) in 10 mL of Freund`s complete adjuvant. Challenge was made 14 days after the last injection using 0.1 mL of sec-alkane sulfonate-sodium salts SAS (60%) at 5% test concentration. Readings performed 24 and 48 hours after the challenge treatment revealed no signs of skin reactions (sensitization incidence = 0%). Additionally, also a second challenge treatment using the same test conditions like in the first challenge revealed no signs of skin reactions (sensitization incidence = 0%). Thus it was concluded that sec-alkane sulfonate-sodium salts SAS is not a skin sensitizer.